Table 1.

Characteristics of HIV-Infected Children Who Survived or Died Within 90 Days or During Follow-up After Starting Highly Active Antiretroviral Therapy

	Alive during follow-up N=128		Death within 90 days N=16		Death during follow-up N=21		p-value* (alive vs. death <90 days, overall)
Female	61 (48%)		8 (50%)		10 (48%)		0.86, 1.00
Age, months	29.1 (19.9, 54.3)		20.4 (14.9, 29.4)		19.1 (14.4, 27.4)		0.02, <0.01
Weight-for-age z-score	−2.33 (−3.15, −1.31)		−3.50 (−4.34, −2.60)		−3.28 (−4.00, −2.16)		<0.01, 0.02
Underweight	73 (57%)		15 (94%)		17 (81%)		<0.01, 0.04
Height-for-age z-score	−2.94 (−4.16, −1.79)	N=124	−3.34 (−4.66, −2.19)	N=13	−3.31 (−4.66, −2.19)	N=18	0.55, 0.54
Stunting	86 (69%)	N=124	10 (77%)	N=13	14 (78%)		0.57, 0.46
Weight-for-height z-score	−0.73 (−1.85, 0.33)	N=101	−2.19 (−3.04, −0.73)	N=13	−1.46 (−3.04, −0.39)		0.03, 0.14
Wasting	21 (21%)	N=101	7 (54%)	N=13	8 (44%)		<0.01, 0.03
Recent illness	97 (76%)		16 (100%)		20 (95%)		0.03, 0.04
Current illness	38 (30%)		8 (50%)		11 (52%)		0.10, 0.04
Hemoglobin, g/dl	9.8 (8.8, 10.9)	N=109	9.3 (9.1, 10.2)	N=12	9.3 (9.0, 10.2)		0.34, 0.37

^*p-values determined using Mann–Whitney U-tests and χ² tests.

Dichotomous characteristics are expressed as N (%) and continuous characteristics as median (interquartile range).